8-KThe Red FlagsRed Alert
Delisting Notice
Filed Mar 20, 2026 · 3mo ago · Accession 0001104659-26-032697
Plain English
TELA Bio, Inc. received a deficiency letter from Nasdaq because its common stock's closing bid price has been below $1.00 per share for 30 consecutive business days. The company has 180 calendar days, until September 14, 2026, to regain compliance.
Filing details
- Company
- TELA Bio, Inc.
- Ticker
- TELA
- CIK
- 1561921
- Form type
- 8-K
- Filing date
- Mar 20, 2026
- Report date
- Mar 17, 2026
- Document
- tm269374d1_8k.htm
- Size
- 186 KB